Milestones
Home / Milestones
Founding and Establishment
The inception of the Apricot Bioscience in August 22, marking its entry into the pharmaceutical industry with Speciality Segment.
Regulatory Approvals
Achieving regulatory approvals from authorities in India regulatory bodies for the Sales and marketing of pharmaceutical products.
Product Development
Successfully developing and launching new drugs or formulations, particularly those addressing unmet medical needs or offering significant therapeutic advancements.
Market Expansion
Entering new markets domestically expanding the company's footprint and reach to serve more patients.
Research and Development (R&D) Achievements
Milestones in R&D, such as breakthrough discoveries, patents granted, or advancements in drug delivery technologies.
Manufacturing Capabilities
Our Manufacturer partners have Expansion of manufacturing facilities, achieving Good Manufacturing Practice (GMP) compliance, and adopting advanced manufacturing technologies to enhance efficiency and quality.
Partnerships and Collaborations
Forming strategic partnerships with research institutions, universities, or other pharmaceutical companies to leverage expertise, access new technologies, or co-develop products.
Sales and Revenue Growth
Achieving significant milestones in sales revenue, demonstrating the company's commercial success and market penetration.
Quality and Compliance
Our Manufacturers Obtaining certifications and accreditations for quality standards, ensuring adherence to Good Laboratory Practices (GLP), Good Clinical Practices (GCP), Android other regulatory requirements under the Guidance of Apricot Bioscience Quality Control Team.
Sustainability Initiatives
Implementing sustainable practices in manufacturing, packaging, and distribution to reduce environmental impact and promote corporate social responsibility.
The Beginning
It started as a dream and became a reality in the year 1995. With training in chemical engineering of Mr Jainesh Jain. The company built up the facility for manufacturing of bulk drugs.
In Action
Unidrug started manufacturing two products in May 1997. With a core focus on quality, we received continuous support from customers. The product portfolio also increased, which enabled Unidrug to see a remarkable increase in satisfied customers year on year including many MNCs.
Achievements
We are long-leading manufacturers of Tinidazole and Ornidazole (both anti protozoal molecules) in India and are looking to expand with several products added to the portfolio.
Mission Ahead
To achieve a turnover of Rs. 70 crores by the year 2024, with its versatile manufacturing unit, latest technology, In-house Research & Development facilities, Process Developments and with a consistent growth rate.